Literature DB >> 8787914

Antibiotic activity in microbiological media versus that in human urine: comparison of ampicillin, ciprofloxacin, and trimethoprim-sulfamethoxazole.

G R Drobot1, J A Karlowsky, D J Hoban, G G Zhanel.   

Abstract

The activities of three antibiotics in both Mueller-Hinton broth (MHB) and pooled human urine were compared by using an in vitro pharmacodynamic model. Clinical and reference strains of Escherichia coli were exposed to antibiotics at concentrations achievable in human urine. The rate of bacterial killing (time to a reduction of 3 log10 CFU/ml) and the extent of bacterial killing at 24 h were examined. Between MHB and urine, there were no significant differences in the rate or extent of bacterial killing for both ampicillin and ciprofloxacin. For trimethoprim-sulfamethoxazole there was no significant difference in the extent of bacterial killing in urine compared with that in MHB (P > 0.1); however, there was a significant decrease in the rate of bacterial killing in urine compared with that in MHB (P < 0.001). We conclude that with ampicillin and ciprofloxacin, activity against E. coli in MHB is predictive of the effects in human urine. The activity of trimethoprim-sulfamethoxazole in MHB predicts the extent but not the rate of bacterial killing in human urine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8787914      PMCID: PMC163091     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

Review 1.  New aspects of prevention and therapy of meningitis.

Authors:  S L Kaplan
Journal:  Infect Dis Clin North Am       Date:  1992-03       Impact factor: 5.982

Review 2.  Short-term treatment of uncomplicated lower urinary tract infections in women.

Authors:  S R Norrby
Journal:  Rev Infect Dis       Date:  1990 May-Jun

3.  Urine as a medium for bacterial growth.

Authors:  A W Asscher; M Sussman; W E Waters; R H Davis; S Chick
Journal:  Lancet       Date:  1966-11-12       Impact factor: 79.321

4.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

Review 5.  Human pharmacodynamics of beta-lactams, aminoglycosides and their combination.

Authors:  G L Drusano
Journal:  Scand J Infect Dis Suppl       Date:  1990

6.  Single dose pefloxacin compared with multiple dose co-trimoxazole in cystitis.

Authors:  E E Petersen; F Wingen; K L Fairchild; A Halfhide; A Hendrischk; M Links; M Schad; H R Scholz; N Schürmann; S Siegmann
Journal:  J Antimicrob Chemother       Date:  1990-10       Impact factor: 5.790

Review 7.  Single-dose antibiotic treatment for uncomplicated urinary tract infections. Less for less?

Authors:  J T Philbrick; J P Bracikowski
Journal:  Arch Intern Med       Date:  1985-09

8.  Influence of human urine on the in vitro activity and postantibiotic effect of ciprofloxacin against Escherichia coli.

Authors:  G G Zhanel; J A Karlowsky; R J Davidson; D J Hoban
Journal:  Chemotherapy       Date:  1991       Impact factor: 2.544

Review 9.  Single-dose versus traditional therapy for uncomplicated urinary tract infections.

Authors:  G G Zhanel; A R Ronald
Journal:  Drug Intell Clin Pharm       Date:  1988-01
  9 in total
  3 in total

1.  Urinary bactericidal activity of extended-release ciprofloxacin (1,000 milligrams) versus levofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.

Authors:  Florian M E Wagenlehner; Martina Kinzig-Schippers; Uwe Tischmeyer; Christine Wagenlehner; Fritz Sörgel; Kurt G Naber
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

2.  Influence of human serum on antifungal pharmacodynamics with Candida albicans.

Authors:  G G Zhanel; D G Saunders; D J Hoban; J A Karlowsky
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

3.  Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: Effect of serum on inhibitory and fungicidal interactions.

Authors:  Antigoni Elefanti; Johan W Mouton; Paul E Verweij; Athanassios Tsakris; Loukia Zerva; Joseph Meletiadis
Journal:  Antimicrob Agents Chemother       Date:  2013-07-15       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.